We are live on ! Find out more

583 hedge funds and large institutions have $14.5B invested in ResMed in 2020 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 197 increasing their positions, 212 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding in top 10

Funds holding in top 10: 10 → 14 (+4)

39% more first-time investments, than exits

New positions opened: 85 | Existing positions closed: 61

12% more call options, than puts

Call options by funds: $52.6M | Put options by funds: $47.2M

11% more capital inflows, than outflows

Capital inflows: $721M | Capital outflows: $651M

4% more funds holding

Funds holding: 560 → 583 (+23)

0.19% more ownership

Funds ownership: 68.03% → 68.21% (+0.19%)

7% less repeat investments, than reductions

Existing positions increased: 197 | Existing positions reduced: 212

Holders
583
Holders Change
+23
Holders Change %
+4.11%
% of All Funds
12.81%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.31%
New
85
Increased
197
Reduced
212
Closed
61
Calls
$52.6​M
Puts
$47.2​M
Net Calls
+$5.44​M
Net Calls Change
-⁠$22.5​M

RMD Hedge Fund Activity: Q1 2020 in Review

583 of the 4,552 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2020, worth a combined $14.5B — down 4.1% from $15.2B a quarter earlier.

Buyers outnumbered sellers: 85 funds opened new RMD positions and 61 closed out — a net gain of 24 holders — while 197 added to existing stakes and 212 trimmed.

The largest buyer was Invesco, adding an estimated $68.9M. The largest seller was American Century Companies, cutting an estimated $77.1M.

  • 583 institutional investors held ResMed (RMD) as of Q1 2020, up from 560 in Q4 2019.
  • Funds reported $14.5B of ResMed stock for Q1 2020, down 4.1% quarter-over-quarter.
  • 85 funds opened new ResMed positions in Q1 2020 and 61 closed out, a net change of +24 holders.
  • The largest ResMed buyer in Q1 2020 was Invesco, an estimated $68.9M added.
  • The largest ResMed seller in Q1 2020 was American Century Companies, an estimated $77.1M sold.

Based on aggregated 13F filings for Q1 2020.